Status:
COMPLETED
The Effect of Non-invasive Hemoglobin Measurement in Hip Surgeries
Lead Sponsor:
Bulent Ecevit University
Conditions:
Bleeding
Hemorrhage
Eligibility:
All Genders
18-60 years
Brief Summary
Bleeding is one of the most important causes of mortality and morbidity in patients. Hb levels are the most prevalently utilized monitoring parameter in hemorrhagic patients in the hemodynamic sense....
Eligibility Criteria
Inclusion
- 18-60 years old
- General anesthesia undergoing hip surgery
- American society of anesthesiology (ASA) scores I-II-III
Exclusion
- Receiving inotropic support
- Uncontrolled diabetes
- Arrhythmia
- Hypothermia
- Hyperbilirubinemia
- Jaundice
- Dark skin pigmentation
- Without voluntary consent
- Hypovolemia,
- hypotension,
- sepsis,
- blood diseases
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04785274
Start Date
January 1 2021
End Date
December 31 2021
Last Update
August 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zonguldak Bulent Ecevit University Medicine Faculty
Zonguldak, Turkey (Türkiye), 67600